ProShare Advisors’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Sell |
|
|||||
|
2025
Q1 | $1.6M | Sell |
|
|||||
|
2024
Q4 | $2.41M | Buy |
|
|||||
|
2024
Q3 | $1.75M | Buy |
|
|||||
|
2024
Q2 | $1.12M | Sell |
|
|||||
|
2024
Q1 | $1.18M | Buy |
|
|||||
|
2023
Q4 | $983K | Buy |
|
|||||
|
2023
Q3 | $562K | Buy |
|
|||||
|
2023
Q2 | $537K | Buy |
|
|||||
|
2023
Q1 | $358K | Sell |
|
|||||
|
2022
Q4 | $406K | Buy |
|
|||||
|
2022
Q3 | $307K | Buy |
|
|||||
|
2022
Q2 | $251K | Sell |
|
|||||
|
2022
Q1 | $480K | Sell |
|
|||||
|
2021
Q4 | $588K | Buy |
|
|||||
|
2021
Q3 | $642K | Sell |
|
|||||
|
2021
Q2 | $908K | Buy |
|
|||||
|
2021
Q1 | $981K | Buy |
|
|||||
|
2020
Q4 | $744K | Buy |
|